Three-dimensional ultrasound evaluation of the pelvic floor in postmenopausal women using hormone therapy
Autor: | Michelle Sako Omodei, Armando Delmanto, Lúcia Regina Marques Gomes Delmanto, Ana Gabriela Pontes, Flávia Neves Bueloni-Dias, Eliana Aguiar Petri Nahás, Daniel Spadoto-Dias |
---|---|
Přispěvatelé: | Universidade Estadual Paulista (Unesp) |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Hormone Replacement Therapy medicine.medical_treatment Pelvic floor Urinary incontinence Palpation General Biochemistry Genetics and Molecular Biology 03 medical and health sciences 0302 clinical medicine medicine Humans Muscle Strength 030212 general & internal medicine Ultrasonography 030219 obstetrics & reproductive medicine medicine.diagnostic_test business.industry Obstetrics Ultrasound Obstetrics and Gynecology Pelvic Floor Middle Aged medicine.disease Postmenopause Menopause Cross-Sectional Studies medicine.anatomical_structure Female Amenorrhea Hormone therapy medicine.symptom business Menopausal hormone therapy Three-dimensional ultrasound Cohort study |
Zdroj: | Scopus Repositório Institucional da UNESP Universidade Estadual Paulista (UNESP) instacron:UNESP |
ISSN: | 0378-5122 |
DOI: | 10.1016/j.maturitas.2020.08.009 |
Popis: | Made available in DSpace on 2021-06-25T10:47:51Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01 OBJECTIVE: To evaluate the three-dimensional (3D) ultrasound characteristics of the pelvic floor muscles (PFM) in two groups of postmenopausal women: users and nonusers of menopausal hormone therapy (MHT). STUDY DESIGN: Observational, cross-sectional cohort study. MAIN OUTCOME MEASURES: In this study 226 sexually active heterosexual women, aged 45-60 years with amenorrhea >12 months and without clinical pelvic floor disorders or urinary incontinence were included. Women using MHT ≥ 6 months were classified as systemic users. PFM strength was assessed by digital vaginal palpation and scored on the Modified Oxford Scale. Biometry of the PFM was performed by 3D transperineal ultrasound for evaluation of total urogenital hiatus area, transverse and anteroposterior diameters, and levator ani muscle thickness. RESULTS: The participants were divided into users (n = 78) and nonusers (n = 148) of MHT. There were no differences in clinical or anthropometric parameters between groups. The mean age was 55 years and the time since menopause was six years in both groups. The mean duration of MHT use was 43.4 ± 33.3 months. Users of MHT had greater levator ani muscle thickness (p = 0.001) and higher PFM strength (p = 0.029) than nonusers. Risk analysis adjusted for age, time since menopause, BMI, parity, and type of delivery showed an association of MHT use with greater levator ani muscle thickness (OR = 2.69; 95% CI 1.42-5.11, p = 0.029), and higher PFM strength (OR = 1.78; 95% CI1.01-3.29, p = 0.046). There was a weak positive correlation between levator ani muscle thickness and duration of MHT use (r = 0.25, p = 0.0002) and PFM strength (r = 0.12, p = 0.043). CONCLUSIONS: Postmenopausal women using MHT had a greater levator ani muscle thickness associated with higher PFM strength than nonusers. Department of Gynecology and Obstetrics Botucatu Medical School Sao Paulo State University - UNESP Department of Gynecology and Obstetrics Botucatu Medical School Sao Paulo State University - UNESP |
Databáze: | OpenAIRE |
Externí odkaz: |